Characteristics

Age (year)

No.

(%)

Characteristics

Cytogenetic Analysis

No.

(%)

Mean ± SD

56.31

±12.3

Normal

20

(44.4%)

Median (Range)

54

(38 - 74)

del 13

4

(8.9%)

≤60 years

25

(55.6%)

del 11

5

(11.1%)

>60 years

20

(44.4%)

Trisomy 12

6

(13.3%)

Sex

del 17

5

(11.1%)

Male

Female

26 (57.8%)

19 (42.2%)

Complex

5

(11.1%)

CD19 (%)

Rai classification

Mean ± SD

82.92

±15.67

Stage 0, 1 & 2

20

(44.4%)

Median (Range)

89.10

(32.84 - 97.61)

Stage 3 & 4

25

(55.6%)

CD23 (%)

Clinical mainfestaion

Mean ± SD

69.40

±27.74

Hepatomegally

22

(48.9%)

Median (Range)

79.27

(0.38 - 95.74)

Lymphadenopathy

31

(68.9%)

CD5/CD20 (%)

Spleenomegally

33

(73.3%)

Mean ± SD

73.22

±23.52

WBCs (×10³/mm³)

Median (Range)

79.90

(8.41 - 96.02)

Mean ± SD

46.80

±31.71

CD79b (%)

Median (Range)

31.60

(17.50 - 122.8)

Mean ± SD

57.18

±33.93

<100 × 10³/mm³

39

(86.7%)

Median (Range)

66.57

(1.93 - 95.51)

≥100 × 10³/mm³

6

(13.3%)

FMc7 (%)

Absolute lymphocytes (×10³/mm³)

Mean ± SD

17.01

±24.89

Mean ± SD

26.27

±16.42

Median (Range)

4.85

(0.06 - 88.44)

Median (Range)

18

(9.10 - 67)

CD22 (%)

<30 × 10³/mm³

33

(73.3%)

Mean ± SD

24.95

±14.39

≥30 × 10³/mm³

12

(26.7%)

Median (Range)

20.79

(7.12 - 70.69)

Platelet count (×10³/mm³)

CD38 (%)

Mean ± SD

121.13

±47.20

Mean ± SD

23.79

±25.41

Median (Range)

111

(45 - 205)

Median (Range)

8

(0.30 - 91.59)

<100 × 10³/mm³

19

(42.2%)

<30%

28

(62.2%)

≥100 × 10³/mm³

26

(57.8%)

>30%

17

(37.8%)

Hemoglobin (g/dl)

MCL-1 (%)

Mean ± SD

10.73

±2.29

Mean ± SD

60.60

±41.98

Median (Range)

10.20

(6.60 - 14.30)

Median (Range)

91.30

(0.60 - 99.70)

<12 g/dl

25

(55.6%)

<25%

18

(40%)

≥12 g/dl

20

(44.4%)

>25%

27

(60%)

LDH (U/L)

BCL-2 (%)